2017
DOI: 10.4172/2167-7964.1000246
|View full text |Cite
|
Sign up to set email alerts
|

Left Ventricular Non-Compaction: Mid-myocardial Distribution of Late Gadolinium Enhancement in Compacted Segments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…Although we found diffusely expanded ECV, LGE was present in only four patients with LVNC (19%), and surprisingly in the medio-basal compacted segments. Compared to other cardiomyopathies, LGE seems to be less frequent in LVNC [35,36], and is observed in both non-compacted and compacted segments [37,38], with a higher prevalence in the compacted ones [38]. This may be explained by the fact that LGE is a marker of focal replacement fibrosis, following cardiomyocyte death in more advanced stages, and not a marker of diffuse interstitial fibrosis, which is better evaluated by T1 mapping [39] and is usually found in LVNC patients on myocardial tissue samples obtained at the time of cardiac transplantation or endomyocardial biopsy [17,40].…”
Section: Lvnc and Myocardial Fibrosismentioning
confidence: 90%
“…Although we found diffusely expanded ECV, LGE was present in only four patients with LVNC (19%), and surprisingly in the medio-basal compacted segments. Compared to other cardiomyopathies, LGE seems to be less frequent in LVNC [35,36], and is observed in both non-compacted and compacted segments [37,38], with a higher prevalence in the compacted ones [38]. This may be explained by the fact that LGE is a marker of focal replacement fibrosis, following cardiomyocyte death in more advanced stages, and not a marker of diffuse interstitial fibrosis, which is better evaluated by T1 mapping [39] and is usually found in LVNC patients on myocardial tissue samples obtained at the time of cardiac transplantation or endomyocardial biopsy [17,40].…”
Section: Lvnc and Myocardial Fibrosismentioning
confidence: 90%